Tokyo Tape
Sign in
← H.U. Group Holdings

Quarterly report · Q3

4544.TEDINET S100SUU5
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥177.5bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥260.9bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥201.0bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income−¥1.1bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥23.7bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income−¥2.9bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥22.0bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥23.2bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax−¥3.2bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥25.8bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)−¥3.3bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥15.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥18.8bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income−¥3.3bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥18.8bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥284.1bnat 2023-12-31Cons.Assets
Total assets¥297.9bnat 2023-03-31Cons.Assets
Total assets¥281.9bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥140.9bnat 2023-12-31Cons.Liabilities
Total liabilities¥147.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥143.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥150.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥153.3bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥40.4bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥44.2bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥40.4bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥44.2bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥30.5bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥46.5bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥9.4bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥32.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥19.2bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥9.2bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥29.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥24.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥4.6bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.8bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥10.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-58.782023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-26.782023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥275.522022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥331.222022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥57.352022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥275.52022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥331.192022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio50.4%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio50.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio54.4%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥4.5bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥4.5bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥4.6bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥110.2bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥110.0bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥214m
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2023-04-01 → 2023-12-31−¥8.6bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥50.7bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥46.4bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥4.3bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥11.0bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2023-04-01 → 2023-12-31¥21.1bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2023-04-01 → 2023-12-31¥21.1bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥4m
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2023-04-01 → 2023-12-31¥938m
—segment totalrevenue2023-04-01 → 2023-12-31¥182.0bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥177.5bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥4.5bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥3.4bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥6.2bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥6.2bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥3.3bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥124.9bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥124.7bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥212m
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.7bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥61.6bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥55.6bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥5.9bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥23.5bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2022-04-01 → 2022-12-31¥20.7bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2022-04-01 → 2022-12-31¥20.6bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥15m
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2022-04-01 → 2022-12-31¥825m
—segment totalrevenue2022-04-01 → 2022-12-31¥207.1bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥201.0bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥6.2bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥26.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 485
ItemContextValueUnit
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration152000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration125000000JPY
Other comprehensive incomePrior1YTDDuration1400000000JPY
Other comprehensive incomeCurrentYTDDuration3816000000JPY
Comprehensive incomePrior1YTDDuration20245000000JPY
Comprehensive incomeCurrentYTDDuration470000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration20245000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration470000000JPY
Income before income taxesPrior1YTDDuration25819000000JPY
Income before income taxesCurrentYTDDuration-3236000000JPY
Depreciation and amortization ope cfPrior1YTDDuration14312000000JPY
Depreciation and amortization ope cfCurrentYTDDuration15181000000JPY
Amortization of goodwill ope cfPrior1YTDDuration133000000JPY
Amortization of goodwill ope cfCurrentYTDDuration220000000JPY
Foreign exchange losses gains ope cfPrior1YTDDuration-304000000JPY
Foreign exchange losses gains ope cfCurrentYTDDuration-760000000JPY
Equity in earnings losses of affiliates ope cfPrior1YTDDuration1315000000JPY
Equity in earnings losses of affiliates ope cfCurrentYTDDuration1844000000JPY
Decrease increase in trade receivables and contract assets ope cfPrior1YTDDuration5153000000JPY
Decrease increase in trade receivables and contract assets ope cfCurrentYTDDuration-754000000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-1776000000JPY
Decrease increase in inventories ope cfCurrentYTDDuration-60000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration-921000000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-2180000000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration-2951000000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration-2813000000JPY
Loss on retirement of noncurrent assets ope cfPrior1YTDDuration60000000JPY
Loss on retirement of noncurrent assets ope cfCurrentYTDDuration863000000JPY
Loss gain on step acquisitions ope cfPrior1YTDDuration-758000000JPY
Loss gain on step acquisitions ope cfCurrentYTDDuration－JPY
Increase decrease in accrued consumption taxes ope cfPrior1YTDDuration-1760000000JPY
Increase decrease in accrued consumption taxes ope cfCurrentYTDDuration795000000JPY
Decrease increase in other current assets ope cfPrior1YTDDuration-317000000JPY
Decrease increase in other current assets ope cfCurrentYTDDuration-843000000JPY
Increase decrease in other current liabilities ope cfPrior1YTDDuration-3989000000JPY
Increase decrease in other current liabilities ope cfCurrentYTDDuration-5554000000JPY
Increase decrease in other noncurrent liabilities ope cfPrior1YTDDuration809000000JPY
Increase decrease in other noncurrent liabilities ope cfCurrentYTDDuration931000000JPY
Other net ope cfPrior1YTDDuration-1909000000JPY
Other net ope cfCurrentYTDDuration-1282000000JPY
Subtotal ope cfPrior1YTDDuration32915000000JPY
Subtotal ope cfCurrentYTDDuration2350000000JPY
Income taxes paid refund ope cfPrior1YTDDuration-13617000000JPY
Income taxes paid refund ope cfCurrentYTDDuration6901000000JPY
Other net ope cf subtotalPrior1YTDDuration-110000000JPY
Other net ope cf subtotalCurrentYTDDuration123000000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration19188000000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration9375000000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration-10592000000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-6398000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass